Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Peter McLaughlin | Researchclopedia

Back to researchers

Peter McLaughlin

Belfast Health and Social Care Trust ORCID

593

Works

25,966

Citations

83

h-index

311

i10-index

Research Topics

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Viral-associated cancers and disorders

Affiliations

Oregon National Primate Research Center1968–1987

Goethe University Frankfurt2015–2021

California Institute of Technology2004–2004

Binghamton University2013–2013

Murray State University1987–1987

Top Works

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

Peter McLaughlin,A.J. Grillo-López,et al.

19982,755 citations

CNS Lymphoma Diagnosis and Treatment

Lung Cancer Treatments and Mutations

Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

Massimo Federico,Monica Bellei,et al.

2009743 citations

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment

Thomas A. Davis,Antonio J Grillo-López,et al.

2000688 citations

Follicular lymphoma international prognostic index.

Philippe Solal-Céligny,Pascal Roy,et al.

2004627 citations

Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)

WS Velasquez,Fernando Cabanillas,et al.

1988580 citations

High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

Jorge Romaguera,Luis Fayad,et al.

2005558 citations

Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

André Goy,Anas Younes,et al.

2004526 citations

Association of serum Rituximab (IDEC–C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin’s lymphoma

Neil L. Berinstein,A.J. Grillo-López,et al.

1998520 citations

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.

William S. Velasquez,Peter McLaughlin,et al.

1994427 citations